North America Primary Angle-Closure Glaucoma Market is expected to grow with the CAGR of 5.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/north-america-primary-angle-closure-glaucoma-market
North America primary angle-closure glaucoma market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
Major players operating in the North America primary angle-closure glaucoma market are introducing a wide range of products along with launching new products and adopting strategic initiatives, such as acquisitions, agreements into the market. This helps companies maximize their sales with enhanced product portfolio.
For instance,
- In June 2020, Johnson & Johnson Vision Care, Inc. has announced to donate to Optometry Cares – The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation. The total amount of USD 0.30 million were donated by the company for the practitioner in their support to provide eye care to the community affected by COVID-19.
Johnson & Johnson Vision Care, Inc. (A Subsidiary of Johnson & Johnson Services Inc.) is the dominating player in North America primary angle-closure glaucoma market. Other key players existing in the market include Bausch & Lomb Incorporated (A Subsidiary of Bausch Health Companies Inc.), ZEISS International, New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (A Subsidiary of AbbVie Inc.), Oertli Instrumente AG, NOVAEYE MEDICAL, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (A Business Unit of Ametek Inc.), and NEW VISION among others.
Johnson & Johnson Vision Care, Inc. (A Subsidiary of Johnson & Johnson Services Inc.)
Johnson & Johnson Vision Care, Inc. (A Subsidiary of Johnson & Johnson Services Inc.) was founded in 1959, and headquartered in Florida, the U.S. The company is focused on providing innovative solutions for most devastating disease in various therapeutic areas involving cardiovascular, immunology among others. It has product categories including contact lens product, ocular surface care, surgical products, in which surgical products is the market focused category.
For instance,
- In October 2019, Johnson & Johnson Vision Care, Inc. announced that they have launched a worldwide #Connected by Sight Campaign in honour of World Sight Day. The pledges was to provide 100,000 children with eye health education and treatment access via Sight for Kids, 1,000 sight-restoring surgeries to cataract patients via the Himalayan Cataract Project and will donate USD 1 to Sight for Kids or the Himalayan Cataract Project for each photo uploaded to Donate a Photo. This initiative helps the company to give their product to be used to increase the company presence for the vision care product
The company has wide presence across Europe, North America, South America, Asia-Pacific, and Middle East and Africa.
Bausch & Lomb Incorporated (A Subsidiary of Bausch Health Companies Inc.)
Bausch & Lomb Incorporated (A Subsidiary of Bausch Health Companies Inc.) was founded in 1853 and is headquartered in New Jersey, the U.S. The company is focused in empowering individuals to detect and learn about their wellbeing, through non-invasive, cost-effective, at-home diagnostics solutions. The product categories of the company includes contact lenses, contact lens care, Rx pharmaceuticals, eye vitamins, surgical instruments, cataract surgery, orthokeratology, vitreoretinal surgery, laser system, veterinary ophthalmology, diagnostics, in which cataract surgery is the market focused category.
For instance,
- In October 2017, Bausch & Lomb Incorporated announced that they have received 510 (k) clearance for the new 3.3 software package from the FDA with new hardware for the new Victus femtosecond laser platform which together are designed to enhance the Victus user experience. This has made the advanced changes in the system and increased the product efficacy.
The company has wide presence across Europe, North America, South America, Asia-Pacific, and Middle East and Africa.
ZEISS International
ZEISS International was incorporated in 1846 and headquartered in Oberkochen, Germany. The company is focused in developing and distributing highly innovative solutions for the industry, quality assurance, life science and for diagnostics and treatment of ophthalmology and microsurgery. It has business segments including semiconductor manufacturing technology, industrial quality & research, medical technology, consumer markets, among which medical technology is the market focused business segment. In addition, the company has various product categories including ophthalmology and microsurgery among which ophthalmology is the market focused category.
For instance-
- In September 2019, Carl Zeiss Meditec presented the surgical product portfolio for the cataract and other related products in the European Society of Cataract and Refractive surgery. This showcase of product will increase the demand for the product among the eye surgeons for surgery for angle closure and other related glaucoma
The company has wide presence across North America, Europe and Asia-Pacific. It has various subsidiary companies such as Carl Zeiss Vision Singapore Pte. Ltd, Carl Zeiss d.o.o (Slovenia), Carl Zeiss Iberia SA, Carl Zeiss (Pty) Ltd, South Africa, Carl Zeiss CO., Ltd. (Taiwan) among others. The company has initiated many strategic initiatives to expand its market.
